The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.
暂无分享,去创建一个
Sameer Bansilal | George Dangas | Krishnan Ramanathan | Alexandra J Lansky | Valentin Fuster | David J Cohen | V. Fuster | M. Domanski | G. Dangas | L. Sleeper | M. Farkouh | K. Ramanathan | A. Lansky | M. Bertrand | D. Cohen | S. Bansilal | J. Tanguay | E. Magnuson | Michael Domanski | Michael E Farkouh | Michel E Bertrand | Lynn A Sleeper | Jean-Francois Tanguay | Whady Hueb | May Ogdie | Elizabeth A Magnuson | Victoria Muratov | W. Hueb | V. Muratov | May Ogdie
[1] R. A. Johnson,et al. Prognostic value of a coronary artery jeopardy score. , 1985, Journal of the American College of Cardiology.
[2] S. Nashef,et al. The logistic EuroSCORE , 2003 .
[3] R. Califf,et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. , 1997, Circulation.
[4] V. Fuster,et al. Optimal treatment of the diabetic patient with multivessel disease , 2008, Current cardiology reports.
[5] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[6] G. Stone,et al. SYNTAX Score Reproducibility and Variability Between Interventional Cardiologists, Core Laboratory Technicians, and Quantitative Coronary Measurements , 2011, Circulation. Cardiovascular interventions.
[7] I. Palacios,et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). , 2005, Journal of the American College of Cardiology.
[8] James T. Willerson,et al. Appointment of New Associate Editor for Circulation , 1996 .
[9] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.
[10] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.
[11] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[12] Mitchell W. Krucoff,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.
[13] W. Howard,et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease , 2008 .
[14] P. Lemos,et al. Coronary Revascularization (Surgical or Percutaneous) Decreases Mortality After the First Year in Diabetic Subjects but not in Nondiabetic Subjects With Multivessel Disease: An Analysis From the Medicine, Angioplasty, or Surgery Study (MASS II) , 2006, Circulation.
[15] F. Welt,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.
[16] R. Frye,et al. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). , 2009, The American journal of cardiology.
[17] Sheng-Chia Chung,et al. Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial , 2008 .
[18] Ameet Bakhai,et al. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.
[19] R. Bonow,et al. The diabetes epidemic: a national and global crisis. , 2004, The American journal of medicine.
[20] J. Spertus,et al. Monitoring the quality of life in patients with coronary artery disease. , 1994, The American journal of cardiology.
[21] Sheng-Chia Chung,et al. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. , 2008, American heart journal.
[22] R A Deyo,et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.
[23] Antonio Colombo,et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. , 2011, European heart journal.
[24] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.
[25] EuroPCR. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. , 2005 .
[26] V. Fuster,et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. , 2008, American heart journal.